• Product NameMontelukast sodium
• Brief DescriptionInhibitors
• Purification99.89%
• Biological ActivityMontelukast sodium is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. It is usually administered orally.D
• Target NameLTR antagonist
• CAS No. 151767-02-1
• Calculated MW 608.17
• Formulation C35H35ClNNaO3S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+]
  Pathways:Immunology/Inflammation
  Receptor:CysLTR1
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 100 mg/mL (164.42 mM); Water: 100 mg/mL (164.42 mM); DMSO: 100 mg/mL (164.42 mM)
  Appearance:White Solid
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Zhang YJ, et al. Acta Pharmacol Sin. 2004 Oct;25(10):1341-6.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting